Elsevier

Psychoneuroendocrinology

Volume 79, May 2017, Pages 134-145
Psychoneuroendocrinology

Salivary diurnal cortisol profiles in patients suffering from chronic breathlessness receiving supportive and palliative care services: A cross-sectional study

https://doi.org/10.1016/j.psyneuen.2017.01.025Get rights and content

Highlights

  • Flatter mean diurnal cortisol slope in patients compared to healthy controls.

  • Differences in mean diurnal cortisol slope depending on severity of breathlessness.

  • Positive correlation for diurnal cortisol slope and MRC dyspnoea grade in patients.

  • Aberrant cortisol profile patterns in patients with moderate-to-severe breathlessness.

Abstract

Chronic breathlessness is a common source of psychological and physical stress in patients with advanced or progressive disease, suggesting that hypothalamic-pituitary-adrenal (HPA) axis dysregulation may be prevalent. The aim of this study was to measure the salivary diurnal cortisol profile in patients receiving supportive and palliative care for a range of malignant and non-malignant conditions and to compare the profile of those experiencing moderate-to-severe disability due to breathlessness against that of patients with mild/no breathlessness and that of healthy controls. Saliva samples were collected over two consecutive weekdays at 3, 6, and 12 h after awakening in 49 patients with moderate-to-severe breathlessness [Medical Research Council (MRC) dyspnoea grade ≥3], 11 patients with mild/no breathlessness (MRC dyspnoea grade ≤2), and 50 healthy controls. Measures of breathlessness, stress, anxiety, depression, wellbeing and sleep were examined concomitantly. The diurnal cortisol slope (DCS) was calculated for each participant by regressing log-transformed cortisol values against collection time. Mean DCS was compared across groups using ANCOVA. Individual slopes were categorised into one of four categories: consistent declining, consistent flat, consistent ascending and inconsistent. Controlling for age, gender and socioeconomic status, the mean DCS was significantly flatter in patients with moderate-to-severe breathlessness compared to patients with mild/no breathlessness and healthy controls [F (2, 103) = 45.64, p < 0.001]. Furthermore, there was a higher prevalence of flat and ascending cortisol profiles in patients with moderate-to-severe breathlessness (23.4%) compared to healthy controls (0%). The only variable which correlated significantly with DCS was MRC dyspnoea grade (rs = 0.29, p < 0.05). These findings suggest that patients with moderate-to-severe breathlessness have evidence of HPA axis dysregulation and that this dysregulation may be related to the functional disability imposed by breathlessness.

Introduction

Chronic breathlessness is a common symptom of advanced cardiorespiratory disease, affecting >90% of people with advanced COPD, >60% of people with advanced heart disease and 10–70% of people with advanced cancer (Solano et al., 2006). It is a considerable source of psychosocial and physical stress, being associated with fear, anxiety, social isolation and functional disability (Booth et al., 2003). It has also been shown to predict mortality, independent of lung function, in a range of conditions, including COPD (Nishimura et al., 2002), pulmonary fibrosis (Nishiyama et al., 2010), and older adulthood (Ahmed et al., 2012). These effects suggest a potential role for the stress hormone system in the experience of breathlessness.

The hypothalamic-pituitary-adrenal (HPA) axis is a major regulator of the physiological stress response, exerting its effects through its end-hormone, cortisol. Basal cortisol secretion has a marked circadian rhythm, characterised by a rapid rise in cortisol secretion upon awakening, followed by a fall in cortisol levels throughout the day (Smyth et al., 2013). This pattern becomes disrupted in the context of prolonged or repeated exposure to stressful triggers, often manifesting as loss or blunting of diurnal variation in cortisol secretion (Miller et al., 2007). Such dysregulation has been observed in a wide range of chronic diseases, both malignant (Abercrombie et al., 2004) and non-malignant (Hackett et al., 2014), and has been associated with negative disease outcomes and characteristics. Flatter diurnal rhythms have been shown to predict mortality secondary to cancer (Sephton et al., 2000, Cohen et al., 2012, Sephton et al., 2013) and cardiovascular disease (Kumari et al., 2011). They have also been associated with more advanced cancer stages (Sephton et al., 2000, Sephton et al., 2013), greater functional disability in cancer (Weinrib et al., 2011, Sephton et al., 2013) and worse physical performance in older adulthood (Gardner et al., 2013).

To date, the relationship of the HPA axis with the physical symptomatology of chronic progressive diseases has been explored to a limited degree only. A few studies have described diurnal cortisol profiles in relation to fatigue in patients with cancer, but findings have been inconsistent (Sephton et al., 2000, Weinrib et al., 2011, Bower et al., 2005, Sephton et al., 2013). One study has identified a relationship between HPA axis function and the cancer symptom cluster of pain, fatigue and depression, but it did not assess diurnal cortisol rhythmicity (Thornton et al., 2010). Symptoms are increasingly understood in the literature to be psychoneurological responses to disease, driven by pathophysiological mechanisms which are distinct from, though related to, the underlying associated disease (Miller et al., 2008, Dantzer et al., 2012, Kim et al., 2012). It is, thus, important to identify these pathophysiological mechanisms to allow therapeutic targeting of symptoms independent of disease.

No studies have examined the relationship between chronic breathlessness and HPA axis function. The literature points to a number of specific factors which are suggestive of a link, however. First, there is a well-established relationship between breathlessness and anxiety (von Leupoldt et al., 2011), which might promote a chronic stress response. Second, the perception of breathlessness is processed in the same parts of the cortico-limbic system (insula, amygdala and anterior cingulate cortex) as other aversive sensations such as pain, hunger and thirst (von Leupoldt et al., 2009), all of which are known to activate the stress response. Finally, the aforementioned independent relationship between breathlessness severity and mortality, across a range of contexts, is currently unexplained; HPA axis dysregulation, in the context of breathlessness, represents one possible explanation needing exploration.

We hypothesised that patients suffering from chronic breathlessness due to chronic progressive disease would have evidence of HPA axis dysregulation, represented by a flatter diurnal cortisol slope. To investigate this, we aimed to measure the salivary diurnal cortisol profile in patients under the care of supportive and palliative care services, who were experiencing moderate-to-severe disability due to breathlessness, comparing this profile against that of non-breathless patients and that of healthy adults. Specific objectives were:

1) To compare the mean diurnal cortisol slope (slope of the decline in cortisol across the day) in patients with moderate-to-severe breathlessness (Medical Research Council, MRC ≥3) against that of non-breathless patients (MRC ≤2) and that of healthy adults.

2) To compare pre-defined diurnal cortisol slope categories between patients with moderate-to-severe breathlessness and healthy adults.

Section snippets

Material and methods

Study procedures for patient participants were approved by the National Research Ethics Service Committee, East of England-Norfolk (13/EE/0021). It was part of a larger programme of research, registered on the ISRCTN registry (ISRCTN70836126). Study procedures for the healthy control group were approved by the ethics committee of the University of Westminster. Written informed consent was obtained from all participants prior to enrolment.

Mean diurnal cortisol slope with respect to health status

To investigate our primary hypothesis that the DCS for patients with moderate-to-severe breathlessness (MRC ≥3) was different from that for patients with mild/no breathlessness and from that of healthy controls, we used a two-stage analysis. First, we calculated the DCS for each patient using linear regression of log-transformed cortisol levels against collection time across the 2 days (6 samples). Second, we assessed whether there was a difference in mean DCS between the three study groups (MRC 

Compliance with the saliva collection protocol

In the patient group, of the 366 commissioned saliva samples from 61 patients, 330 (90.2%) were collected within 1 h of the time stipulated by the protocol, 3 (0.8%) were missing and 15 (4.1%) had no collection time recorded. In regard to the self-reported awakening time, which was the anchor for the subsequent collection times, this was within 15 min of the objective actigraphy-derived awakening time on 78% of the days recorded (n = 38).

Protocol-compliance in the patient group is summarised at a

Discussion

We have described the salivary diurnal cortisol profile, a surrogate marker of HPA axis activity, in patients suffering from moderate-to-severe breathlessness (MRC ≥3) secondary to a range of cardiorespiratory diseases. We have shown that patients with moderate-to-severe breathlessness had significantly flatter diurnal cortisol slopes compared to healthy adults. We have also shown that patients with moderate-to-severe breathlessness had a mixture of declining, flat and ascending slopes, a

Conclusion

In summary, this cross-sectional study provides novel evidence of HPA axis dysregulation in patients with moderate-to-severe breathlessness, manifesting as flatter diurnal cortisol decline slopes. The degree of dysregulation appears to relate to functional disability due to breathlessness, rather than psychological distress. Future longitudinal studies are necessary to explore the temporal relationship between breathlessness-induced disability and HPA axis dysregulation, as well as its

Acknowledgements

The authors would like to thank the following people for their support of the study: all patients who participated; past and present staff of the Cambridge Breathlessness Intervention Service and the Palliative Care Department of Cambridge University Hospitals NHS Foundation Trust, particularly those who helped with recruitment and administration (in particular, Dr. Rosemary Wade, Julie Burkin, Pauline Kleanthous, Catherine Moffat, Rhys Hurst, Malika Harboun, Natalie Brown and Dr. Sarah Grove);

References (53)

  • K. Nishimura et al.

    Dyspnea is a better predictor of 5-year survival than airway obstruction in patients with COPD

    Chest

    (2002)
  • J.D. Rosenblat et al.

    Inflamed moods: a review of the interactions between inflammation and mood disorders

    Prog. Neuropsychopharmacol. Biol. Psychiatry

    (2014)
  • S.E. Sephton et al.

    Diurnal cortisol rhythm as a predictor of lung cancer survival

    Brain Behav. Immun.

    (2013)
  • J.M. Smyth et al.

    Individual differences in the diurnal cycle of cortisol

    Psychoneuroendocrinology

    (1997)
  • J.P. Solano et al.

    A comparison of symptom prevalence in far advanced cancer, AIDS, heart disease, chronic obstructive pulmonary disease and renal disease

    J. Pain Symptom Manag.

    (2006)
  • A.A. Stone et al.

    Individual differences in the diurnal cycle of salivary free cortisol: a replication of flattened cycles for some individuals

    Psychoneuroendocrinology

    (2001)
  • A. von Leupoldt et al.

    Dyspnea and pain share emotion-related brain network

    Neuroimage

    (2009)
  • A. von Leupoldt et al.

    The impact of anxiety on the neural processing of respiratory sensations

    Neuroimage

    (2011)
  • E.K. Adam et al.

    Day-to-day dynamics of experience–cortisol associations in a population-based sample of older adults

    Proc. Natl. Acad. Sci. U. S. A.

    (2006)
  • N.E. Adler et al.

    Relationship of subjective and objective social status with psychological and physiological functioning: preliminary data in healthy white women

    Health Psychol.

    (2000)
  • T. Ahmed et al.

    Dyspnoea and mortality in older people in the community: a 10-year follow-up

    Age Ageing

    (2012)
  • J.C. Bestall et al.

    Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease

    Thorax

    (1999)
  • S. Booth et al.

    Breathlessness in cancer and chronic obstructive pulmonary disease: using a qualitative approach to describe the experience of patients and carers

    Palliat. Support. Care

    (2003)
  • K. Boyne et al.

    Accuracy of computer algorithms and the human eye in scoring actigraphy

    Sleep Breath.

    (2013)
  • S. Cohen et al.

    Perceived stress in a probability sample of the United States

  • S. Cohen et al.

    Socioeconomic status, race, and diurnal cortisol decline in the coronary artery risk development in young adults (CARDIA) study

    Psychosom. Med.

    (2006)
  • Cited by (12)

    • Systematic review of the literature on the occurrence and characteristics of dyspnea in oncology patients

      2023, Critical Reviews in Oncology/Hematology
      Citation Excerpt :

      A plausible hypothesis to explain the relationship between stress and dyspnea is that stress activates the hypothalamic-pituitary-adrenal (HPA) axis (Ryan et al., 2014). This dysregulation results in negative immunological, metabolic, and neuropsychological sequelae (Abelson et al., 2010; Ryan et al., 2014; Ryan et al., 2016; Ryan et al., 2017), that contribute to increases in dyspnea’s severity and/or distress. However, no studies have evaluated for associations between dyspnea and stress in oncology patients.

    • “It made me feel brighter in myself”- The health and well-being impacts of a residential front garden horticultural intervention

      2021, Landscape and Urban Planning
      Citation Excerpt :

      Salivary cortisol data was collected following the procedures outlined by Roe et al. (2013). This data allows the modelling of trends and changes in the daily lives of research participants (Schlotz, 2018). Diurnal cortisol profiles (declines after waking - see Introduction) were monitored by collecting saliva samples four times a day (3, 6, 9, and 12 h after waking) for each individual for two consecutive days with cotton swabs and Salivette collection tubes (Smyth et al., 2013).

    • Effectiveness of stress-relieving strategies in regulating patterns of cortisol secretion and promoting brain health

      2020, International Review of Neurobiology
      Citation Excerpt :

      Mindfulness-based interventions conducted with clinical populations have also been shown to be effective in reducing self-reported stress from pre- to post-intervention and in comparison, to control groups (Mackenzie, Carlson, & Speca, 2005; Ott, Norris, & Bauer-Wu, 2006; Smith, Richardson, Hoffman, & Pilkington, 2005), and some studies show sustained effects for up to 6-months (e.g., Carlson, 2018). Much of the research has been conducted on cancer patients, an ideal group to study as they experience high levels stress and aberrant cortisol profiles (e.g., Ryan et al., 2017). Mindfulness-based interventions were most effective in reducing cortisol levels for breast cancer patients who displayed the highest cortisol levels pre-intervention (Carlson, Speca, Patel, & Goodey, 2004).

    • Chronophysiological features of the normal mineral composition of human saliva

      2017, Archives of Oral Biology
      Citation Excerpt :

      The conducted studies have demonstrated that the mineralizing function of saliva is significantly dependent on the near-24-h dynamics of the calcium and inorganic phosphorus concentrations. It would be reasonable to assume that the dynamics of the saliva electrolyte levels largely stems from the diurnal changes in the saliva flow rate (Rapoport, 2012; Rodrigues et al., 2016; Ryan et al., 2017). However, the Spearman’s correlation coefficients only suggest that there is a moderate positive correlation between the saliva flow rate and pH (R = 0.4978, p < 0.05), and a negative correlation between the saliva flow rate and sodium concentrations (R = −0.5206, p < 0.05).

    View all citing articles on Scopus
    View full text